How to Get Testosterone Enanthate in North Carolina

North Carolina Prescribing Rules for Testosterone Enanthate

Testosterone enanthate is a Schedule III controlled substance under both federal law and North Carolina General Statute §90-91. Any provider with an active DEA registration and a North Carolina medical license can prescribe it. The NC Medical Board does not impose additional restrictions beyond federal scheduling requirements for testosterone prescribing.

Who Can Write the Prescription

MDs and DOs prescribe independently. Nurse practitioners in North Carolina operate under a collaborative practice agreement with a supervising physician, per NC General Statute §90-18.2, though a 2024 update expanded NP autonomy after 10,000 supervised clinical hours 1. Physician assistants also prescribe Schedule III substances under physician supervision. All three provider types can initiate testosterone enanthate therapy provided the diagnosis meets clinical criteria.

Telehealth Prescribing in NC

North Carolina's telehealth statute (Session Law 2021-26) permits prescribing controlled substances via audio-video visits when a valid provider-patient relationship exists. The Ryan Haight Act requires at least one real-time interaction before a Schedule III prescription can be issued. Platforms like HealthRX connect NC patients with licensed providers who can order labs, evaluate results, and transmit prescriptions to local or mail-order pharmacies without an in-person visit.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with "unequivocally low serum testosterone levels and clinical signs and symptoms of androgen deficiency" 2. This standard applies regardless of whether the visit is in-person or virtual.

Getting Diagnosed: Labs and Clinical Criteria

Before any NC provider can prescribe testosterone enanthate, you need laboratory confirmation of hypogonadism. A single blood draw is not enough. The American Urological Association and the Endocrine Society both require two separate morning samples showing total testosterone below 300 ng/dL 2.

Required Bloodwork

The minimum lab panel includes total testosterone (drawn between 7:00 and 10:00 AM), free testosterone or SHBG, complete blood count (CBC), comprehensive metabolic panel, and a lipid panel. Men over 40 also need a baseline PSA and digital rectal exam. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) help distinguish primary from secondary hypogonadism, which changes the treatment approach.

What the Numbers Mean

The T-Trials (N=790), published in the New England Journal of Medicine in 2016, enrolled men aged 65 and older with total testosterone below 275 ng/dL. Participants who received testosterone gel for 12 months showed significant improvements in sexual function, walking distance, and mood compared to placebo 3. While those trials used transdermal gel rather than enanthate injections, the diagnostic threshold and clinical endpoints apply to all testosterone formulations.

A 2020 meta-analysis of 30 RCTs (N=1,731) in the Journal of Clinical Endocrinology & Metabolism found that intramuscular testosterone enanthate produced a mean total testosterone increase of 288 ng/dL from baseline at steady state, with peak levels occurring 24 to 48 hours after injection 4.

Pharmacy Options in North Carolina

Once your provider transmits the prescription, you have two main dispensing routes: retail chain pharmacies and 503A compounding pharmacies. Both are available across the state.

Retail Pharmacies

CVS, Walgreens, and independent pharmacies throughout NC stock manufactured testosterone enanthate (brand Delatestryl and generics). A 5 mL vial of 200 mg/mL typically costs $40 to $90 without insurance. GoodRx-style discount cards can reduce this further. The FDA-approved labeling for testosterone enanthate lists the standard intramuscular dose at 50 to 400 mg every two to four weeks, though most TRT protocols now favor weekly injections of 100 to 200 mg for more stable serum levels 5.

503A Compounding Pharmacies

North Carolina licenses 503A compounding pharmacies under the NC Board of Pharmacy. These pharmacies can prepare custom testosterone enanthate formulations (different concentrations, carrier oils, or combination vials with other compounds) based on a patient-specific prescription. 503A pharmacies in NC can ship directly to the patient within the state.

Compounded testosterone enanthate costs vary. Expect $30 to $70 per month depending on dose and pharmacy. Compounded vials are not FDA-approved products, but they are legal when prepared under a valid prescription by a licensed 503A facility.

Insurance Coverage and Cost in North Carolina

Coverage depends heavily on your plan type. The field for testosterone reimbursement in NC splits along a clear line: commercial insurance versus Medicaid.

Commercial Insurance

Most Blue Cross Blue Shield of North Carolina, Aetna, Cigna, and UnitedHealthcare plans cover testosterone enanthate for diagnosed hypogonadism with prior authorization. The prior auth process typically requires documentation of two low testosterone lab results, a clinical note describing symptoms, and confirmation that contraindications (untreated polycythemia, PSA above 4 ng/mL, active breast or prostate cancer) have been ruled out 6.

Turnaround for NC prior authorization is usually 3 to 5 business days. If denied, your provider can file a peer-to-peer appeal. Copays on approved prescriptions range from $10 to $50 per fill at preferred pharmacies.

NC Medicaid

North Carolina Medicaid does not cover testosterone enanthate for male hypogonadism. Coverage is restricted to type 2 diabetes indications only. This is a significant gap for Medicaid-enrolled men in the state. Cash-pay pricing or compounding pharmacy routes become the primary options for these patients.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted: "The exclusion of testosterone therapy from state Medicaid formularies creates a two-tiered system where men with low income and documented hypogonadism cannot access a treatment that is standard of care" 7.

Step-by-Step Process: First Visit to First Injection

The timeline from initial consultation to your first injection in North Carolina typically runs 7 to 14 days. Here is the sequence.

Week One: Consultation and Labs

Schedule a telehealth or in-person visit with a licensed NC provider. During that visit, the provider reviews symptoms (fatigue, low libido, depressed mood, reduced muscle mass) and orders the lab panel. Most patients complete labs within 1 to 3 days at a Quest Diagnostics or Labcorp location. North Carolina has over 200 patient service centers between these two networks.

Week Two: Results, Prescription, and Dispensing

If labs confirm hypogonadism (total testosterone <300 ng/dL on two draws), the provider writes the prescription. For telehealth platforms, the prescription is electronically transmitted to your chosen pharmacy. Retail pharmacies usually fill within 24 to 48 hours. Compounding pharmacies may take 3 to 5 business days, with shipping adding 1 to 2 days.

Your provider will also prescribe injection supplies (syringes, needles, alcohol swabs) or instruct you on self-injection technique. Most NC patients self-administer intramuscular injections at home using a 22- to 25-gauge, 1-inch needle in the vastus lateralis (outer thigh) or deltoid.

Monitoring and Follow-Up Requirements

Starting testosterone is not a one-time event. NC providers are expected to follow the Endocrine Society's monitoring protocol, which calls for bloodwork at 3 months, 6 months, and then annually 2.

What Gets Checked

Follow-up labs include total testosterone (drawn at trough, the morning before your next injection), hematocrit, hemoglobin, PSA (men over 40), and a lipid panel. Hematocrit is the most common safety concern. The Endocrine Society guideline recommends holding or reducing the dose if hematocrit exceeds 54%, due to increased thrombotic risk 2.

Red Flags That Require Action

A 2010 study in the New England Journal of Medicine (TOM Trial, N=209) found that men aged 65 and older with mobility limitations who received testosterone gel experienced a higher rate of cardiovascular events compared to placebo, prompting the FDA to require a cardiovascular risk warning on all testosterone products 8. Subsequent larger trials, including TRAVERSE (N=5,246), showed no significant increase in major adverse cardiovascular events (MACE) with testosterone versus placebo over a median 33-month follow-up (hazard ratio 0.96, 95% CI 0.78 to 1.17) 9.

Dr. Shalender Bhasin, principal investigator of the TRAVERSE trial and Professor of Medicine at Harvard Medical School, stated: "These findings provide reassurance that testosterone replacement therapy in men with hypogonadism and established or high risk for cardiovascular disease does not increase the incidence of major adverse cardiac events" 9.

Ongoing Monitoring Schedule

Expect to have bloodwork drawn at minimum every 6 to 12 months once stable. Your provider should assess symptom response, check for polycythemia, and evaluate prostate health annually. Bone mineral density testing may be warranted after 1 to 2 years in men with baseline osteopenia.

Transferring a Prescription to North Carolina

If you have an existing testosterone enanthate prescription from another state, NC pharmacies can accept a valid transfer. The sending pharmacy contacts the receiving NC pharmacy directly. Because testosterone enanthate is Schedule III, federal law permits one transfer between pharmacies unless the prescription was written as a refillable Rx, in which case remaining refills can transfer.

Your out-of-state telehealth provider must hold a North Carolina medical license (or the platform must employ a provider who does) for ongoing prescriptions. A one-time transfer of existing refills does not require the prescriber to be NC-licensed, but new prescriptions do.

Why Telehealth Has Changed NC Access

Before telehealth expansion, men in rural NC counties (Robeson, Tyrrell, Hyde) often drove 60 or more miles to reach an endocrinologist or urologist. The 2021 NC telehealth statute permanently codified pandemic-era flexibilities, making it possible to complete the entire TRT workflow from a phone or computer. A 2022 JAMA Network Open analysis found that telehealth-initiated testosterone prescriptions increased 121% nationally between 2019 and 2021, with the largest gains in rural and medically underserved areas 10.

This access shift matters. The CDC estimates 4 to 5 million American men have symptomatic hypogonadism, but fewer than 10% receive treatment 11. In a state like North Carolina, where 80 of 100 counties are classified as medically underserved, telehealth closes a real gap.